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Clinical rubella in the first trimester of pregnancy may result in congenital 
anomalies of the infant, as was first noted in Australia by Gregg (1).  In 1964 
and  1965 widespread epidemics of congenital rubella occurred in  the United 
States in which thousands of infants were born with more severe malformations 
than had previously been described (2-4).  Before methods were available for 
isolation of rubella virus,  the  anomalies were  attributed to  the effect of the 
virus upon the developing fetus during a  critical period of organ formation. 
More recently, however, studies have demonstrated excretion of virus by the 
infants and persistence of the virus in infant's tissues for at least a year after 
birth (2-8). This virus persistence occurs despite the development of neutraliz- 
ing antibodies to rubella in the infant's serum (9-13). 
During a study of postmortem tissues from infants with congenital rubella, 
we found that tissue cultures could be derived from various organs and that 
these cultured tissues, even though they appeared normal, were infected with 
rubella virus (6).  In some instances the infected tissue cultures developed into 
cell strains which resulted in the establishment of spontaneous rubella cartier 
cultures. This in vitro model of the symbiotic relationship between the infant 
ceils and rubella virus was investigated in an attempt to obtain a possible ex- 
planation for the in vivo observation of persistent infection. 
Materials and Methods 
Tissue  Cultures.--The preparation of rubella infected cell strains from infants with con- 
genital rubella has been previously described (6); the method followed was that used by Ben- 
yesh-Melnick et al.  (14)  for isolating cytomegalovirus, adenovirus,  measles, coxsackie,  and 
varicella viruses from a variety of infant organs obtained at postmortem. Bone marrows were 
grown as described by Benyesh-MeLuick et al.  (15). Similar techniques were applied for the 
preparation of normal, noninfected cell strains from postmortem tissues of infants without 
evidence of rubella.  Primary African green monkey kidney  (GMK)  cells were prepared as 
described (16),  and in addition a line of monkey cells BSC-1  (17)  was used. Constricted cul- 
ture tubes were used,  as they produced  more uniform monolayer cultures which were con- 
veniently restricted to one part of the tube (18).  1 oz fiat bottles were used for some experi- 
ments and for all plaque assays. 
Med/a.--Growth medium for cell strains derived from infants consisted of Eagle's basal 
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medium supplemented with 10% fetal bovine serum, antibiotics (penicillin, 100 units/ml and 
streptomycin:  100 #g/ml), and 0.75 g/liter of bicarbonate.  Maintenance  medium for cell 
strains derived from infants and for GMK cells consisted of Eagle's basal medium with 2% 
fetal bovine serum, antibiotics, and 1.5 g/liter of bicarbonate. This medium was also used for 
growth of BSC-I cells. 
Viruses  and  Virus Assays.--Virus  stocks were prepared in monolayers of cells grown in 
16-oz. prescription bottles. The growth medium was removed from the monolayers, 0.5 to 1 
ml of seed virus was added and after an adsorption period of 1 hr at 37°C, the monolayers 
were washed once with maintenance medium. The cells were incubated  in the presence of 
maintenance medium after which the viruses were harvested by freezing the cultures in a dry 
ice--alcohol bath and thawing. Virus-containing materials were clarified by low speed centrifu- 
gation, ampuled, and stored at --35°C. 
Rubella virus assays were performed utilizing the inhibition  of the cytopathic effect (CPE) 
of echovirus 11 in GMK cells (19). Rubella virus titers  are expressed as inhibitory dose~ 
(InDs0) which represents the dilution of virus necessary to prevent echovirus 11 CPE in 50% 
of the tubes upon challenge. Echovirus 11  (Gregory) was obtained from the World Health 
Organization Enterovirus Reference Centre, Houston, and passed in GMK cells. The virus 
was assayed by the plaque-counting method in GMK cell monolayers as used in this labora- 
tory (20). In some instances the virus was assayed in culture tubes containing  monolayers of 
GMK cells or human lung fibroblasts. Four tubes were employed per 10-fold dilution and the 
tissue culture infectivity dose (TCDs0) was calculated by the method of Reed and Muench (21). 
Herpes simplex virus  (Black) was a laboratory strain. Virus stock was prepared  in human 
lung fibroblasts, ampuled, and  stored  at  --90°C. The virus was assayed by titrations in 
culture tubes containing monolayers of human lung fibroblasts. Vesicular stomatits  virus 
(VSV) used in this laboratory  has been described by McCombs et al.  (22). The virus had 
been passed several times in human lung fibroblasts before preparation  of virus stock in 
GMK cells. The virus was assayed by the plaque-counting method in BSC-1 cells. Following 
virus inoculation and a  1 hr adsorption period, the cells were overlayed with Eagle's basal 
medium, 1.5% Bacto-Agar (Difco Laboratories, Inc., Detroit),  antibiotics, neutral red, 2.25 
g/liter bicarbonate, and 3% fetal bovine serum. Plaques were counted in 2 or 3 days. 
An~serum.--Rubella  antiserum was prepared in baboons. Animals were inoculated intra- 
muscularly twice, 3 wk apart, with 3 ml virus stock (Ellis strain, 103"5 InD~/ml) mixed with 
an equal volume of Freund's complete adjuvant and at the same time intravenously  with 3 
ml of virus fluid. Serum drawn 8 wk after the second inoculation was found to have a titer 
of 1/256. The neutralization test was essentially that described by Parkman et al. (23). 
EX:PERIM:ENTAL 
Sixty-eight attempts were made  to  establish cell strains from infants with 
congenital rubella in Houston  (2).  Primary cell monolayers developed in  11 
instances and 10 of these were found to be spontaneously infected with rubella 
virus. Five of the infected cell monolayers were successfully subcultivated into 
cell strains. These included cell strains derived from thyroid, umbilicus, lung, 
bone marrow, and kidney which were designated as rubella infected cell strains 
R-1 through R-S, respectively. Noninfected cell strains were also developed from 
tissues of infants without evidence of congenital rubella and from one infant 
with congenital rubella. The noninfected cell strains were designated as control 
cell strains C-1 through C-4, and included lung from the infant with congenital 
rubella and lung, umbilicus, and thyroid from infants without rubella, respec- 
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Attachment and growth of cells following trypsinization of tissues from con- 
genital rubella infants were usually notas good as with cells derived from infants 
without evidence of congenital rubella. Once monolayers formed, it was pos- 
sible to perform serial passages readily twice weekly for 8  to  10 subcultures. 
Serial passage of cells,  which was performed when a  complete monolayer de- 
veloped (5 to 6 X  10  6 cells), was then possible at weekly intervals for an addi- 
tional 8  to  10 passages.  Thereafter the monolayers required many weeks  to 
develop and subcultivations were performed infrequently. It was possible  to 
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Fro. 1. The passage history of R-1 thyroid chronically infected cell strain in relation to 
spontaneous production  of rubella virus. (A, indicates day of subcultivation; 0, indicates ru- 
bella titers in tissue culture fluid). 
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maintain  R-I  thyroid  cells  for  II  months  through  23  subcultivations.  The 
passage history of the first 21 subcultivations of these cells is shown in Fig.  I 
and is representative of the passage histories found with the other chronically 
infected cell strains. R-2 umbilicus was also maintained for I 1 months and 23 
subcultivations. R-3 lung survived for 3 months and  14 subcultivations while 
R-4 bone marrow survived 7 months and 14 subcultivations. The infected cell 
strain derived from kidney tissue has been developed more recently and has 
undergone 12 subcultlvations over a 3 month period. It appears that the chroni- 
cally infected cell strains may enter a slow growth phase (24) more rapidly than 
the  noninfected cell  strains.  Morphologically the  cells  were  fibroblasts  and 
could not be distinguished from noninfected cells. Staining with acridine orange 798  RUBELLA  VIRUS  CARRIER  CULTURES 
and with hemotoxylin and eosin stains did not reveal any specific characteristic 
features of the infected cells. 
Rubella virus could be demonstrated at concentrations of 104.°-10 6.5 InD60/ 
ml in  the  tissue culture fluid  throughout  the life of the cultures.  This  repre- 
sented about 1 to 10 InDs0 of rubella virus in the culture fluid per cell. 
The  multiplication  of  chronically infected  cell  strains  was  examined  and 
compared with that of the noninfected cell strains. 
Experlment.--CeUs were dispersed by trypsinization and suspended in growth medium at 
3.5 to 5 >( 104/ml. Constricted culture tubes were seeded with 1 ml cell suspension and incu- 
bated in stationary racks with medium changes performed at 3- to 5-day intervals. At inter- 
vals of 1 to 3 days, 3 tubes of each cell strain examined were drained of their medium and 
washed once with salt solution. The monolayers were drained of the wash fluid then covered 
with 1 ml of 0.2% trypsin. The tubes were incubated at 37°C for 30 rain, when the cells were 
dispersed by pipetting, and were counted in a hemocytometer.  The average of the cell numbers 
obtained for the 3 tubes was taken as the final count. 
Representative growth  curves  of early and  late passages of chronically in- 
fected cells, together with the growth curves of noninfected cultures, are shown 
in  Fig.  2.  Multiplication of chronically infected cell strains  was  found  to  be 
impaired. The 4 noninfected fibroblast cell strains doubled their cell number in 
24  hr  during  the rapid growth  phase.  This generation  time  was  obtained re- 
peatedly and is in agreement with reports of others (24). Early in the life of the 
chronically infected cultures a  generation time of about 48 hr was obtained as 
shown  in  Fig.  2  but  beyond  10  subcultivations multiplication was  more  re- 
tarded with a  doubling time of about 72 hr. 
Carrier states  of animal viruses in  cell cultures have  been  shown  in many 
instances to depend upon  the presence in the culture fluid of a  viral inhibitor 
(see  reviews  by  Ginsberg  (25)  and  Walker  (26)).  These  have  included  both 
specific viral antibodies and nonspecific serum factors which inhibit virus multi- 
plication (27). Therefore,  a possible inhibitory effect of the fetal bovine serum 
used in the medium of chronically infected cell strains was sought. 
Experiment.--R-2 umbilicus cells passage 18 were planted in culture tubes and allowed to 
develop into monolayers. The tubes were divided into 3 groups. The monolayers were washed 
with serum-free medium and each group of tubes received 1 ml of (a) medium with 10% fetal 
bovine serum, (b) medium with 2% fetal bovine serum, and (c) medium with no serum supple- 
ment. Tubes were observed daily for CPE and at intervals the fluid from 3 tubes was pooled 
and titered for virus. Cell counts were performed  at the onset, 3rd, 7th and 10th day of the 
experiment. Noninfected C-1 lung cells were placed on similar media and observed concur- 
rently with the infected cells. 
Rounding and mild degenerative changes were noted at 7 to 10 days in some 
of the  chronically infected cells maintained  on  serum-free medium; however, 
similar changes were observed in control cells on the same medium. No cellular 
degeneration  was  noted  in  the  monolayers  maintained  on  media  containing WILLIAM  E,  RAWLS  AND  JOSEPH  L.  MELNICK  799 
serum. Rubella virus concentrations in the culture fluid increased over the first 
3 days then remained fairly constant thereafter at a  ratio of about  10 InDs0 
virus/cell. As  shown in  Fig.  3,  virus yield was  no greater in the absence of 
serum. The cell numbers appeared to decrease slightly in the absence of serum, 
increase slightly in the presence of 10 % serum, and remain about the same in 
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FIo. 2. Growth curves of rubella  carrier  culture cells  and control cells. (O, C-1 lung passage 
13; ~, C-1 lung passage 17; ~,  C-3 umbilicus passage 6). 
the presence of 2 %  serum. These findings reveal no inhibitory effect of fetal 
bovine serum on rubella virus. 
Interferon produced by affected cells of a carrier culture may protect other 
cells from infection by the persistent virus  thus  allowing a  balance of virus 
production and cell survival (28). Our attempts to demonstrate interferon in 
tissue culture fluid from rubella carrier cultures were unsuccessful. These at- 
tempts included assay by plaque reduction of the indicator vesicular stomatitis 
virus (VSV), as well as suppression of CPE in tubes challenged with 100 TCD60 
VSV, after overnight exposure of human lung fibroblasts or human embryonic 
kidney cells to carrier culture fluid which had been centrifuged at 25,000 m,• 8OO 
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FIO.  3.  The effect of different concentrations of fetal bovine serum on rubella virus pro- 
duction in chronically infected cells. 
for 1 hr (to remove virus but not interferon). Interferon prepared by infecting 
human  embryonic kidney cells  with  attenuated  measles  virus  (Edmonston 
strain) protected human lung fibroblasts from VSV challenge, with the tissue 
culture fluid yielding a titer of 1: 8. This material was used as a control. Incuba- 
tion of human lung fibroblasts for 2 hr with undiluted, uncentrifuged tissue cul- 
ture fluid from chronically infected cells did not alter the single cycle growth 
curves of VSV (29) or echovirus 11. WILLIAM  E.  1LAWLS AND  ~OSEPH  L.  MELNICK  801 
Carrier cultures have been described by Henle et al.  (30) in which interferon 
was not demonstrated in undiluted tissue culture fluid but could be found after 
concentration. Therefore, the possible role of interferon in the maintenance of 
the rubella infected cell strains was further investigated by applying methods 
known to destroy or interfere with the action of interferon (31). These methods 
included the incorporation into the medium of trypsin which destroys interferon 
and cortisone acetate which inhibits interferon activity (32). 
Experiment.--Cniture tubes containing monolayers of infected and noninfected tubes were 
drained of their  medium and washed with Eagle's medium without serum. Portions of each 
group received the following medium: (a) growth medium without serum containing 0.005% 
trypsin (Difco, 1/250);  (b) growth medium without serum;  (c) growth medium containing 2 
#g/ml of cortisone acetate; and (d] standard growth medium with serum. Tubes were observed 
daily for CPE and 2 tubes of each group were frozen, thawed, and assayed for rubella virus. 
TABLE  I 
The Effects of Cortisone and Trypsin on Chronically Infected Cells* 
Medium 
Trypsin 0.005% in serum free medium 
Serum-free medium 
Cortisone 2/~g/ml growth medium 
Growth medium 
Titer$ after incubation period of 
io~.41  i¢.o  I i~.4[  I¢-~[  io~.8 ]_>io3.,  1 io4., 
io4.~ [ i~.8[  I~~I  IO  3-4 ] i~~I  I~"I  io,.3 
IO~." l IO'-~I io4.~l  1o,.51  I  Io,.4  ] 
1o,., 11o,.  1 i,.811,.  1  I 
* No cytopathic effect was seen during the period of observation. 
~: Rubella titer, inhibitory  doseso/ml. 
The  results  of the  experiments  are  shown  in  Table  I.  Neither  cytopathic 
effect  nor  higher  rubella  virus  titers  developed  in  the  cultures  treated  with 
either cortisone or trypsin. These data suggest that the maintenance of persist- 
ent infection in rubella infected cell strains is not dependent on interferon. 
Essential in the characterization of a virus carrier state is the determination 
of  the  proportion  of  the  cell  population  infected  by  the  virus  (26).  Hypo- 
thetically a single virus-producing cell might be able to produce enough rubella 
virus  to confer interference  in  GMK cells.  Consequently studies  were under- 
taken  to establish  the number of chronically infected cells needed  to produce 
such interference. 
Experiment.--Monolayers of  chronically infected cells were  washed  with  salt  solution, 
tryps'mized, and resuspended in growth medium. The cells were sedimented by centrifugation 
at 800 al,  M for 10 rain, washed with salt  solution, resuspended in the Earle's solution, and 
divided into two equal parts.  To one portion was added  10% normal baboon serum and to 
the other was added 10% rubella antiserum prepared in baboons. The mixtures were held at 
room temperature  for 1 hr after which the cells were sedimented and resuspended in Earle's 802  RUBELLA  VIRUS  CARRIER  CULTURES 
solution. Cell counts were performed and further dilution of the ceils was made to provide 
the desired number of cells per 0.1 hal. Cells were inoculated into culture tubes containing 
GMK monolayers from which the medium had been drained. 1 hr later 1 ml of maintenance 
medium was added and the tubes incubated in a stationary rack at 37°C. The medium was 
changed in 7 days and the tubes inoculated with 100 TCDs0 echovirus 11 after 14 days. 
The results of an experiment performed with R-2 umbilicus cells are shown 
in  Table II. All  GMK monolayers receiving more than  a  calculated  15  cells 
and some of the tubes receiving less cells were resistant  to echovirus 11.  The 
number of cells producing interference in 50 %  of the inoculated tubes was 3.8 
and  1.4  for  cells  treated  with  normal  baboon  serum  and  rubella  antiserum, 
respectively. 
TABLE  II 
Determination of the Number of Cdls Infected in R-2 Umbilicus 
Carrier Culture 
Ceils plus  normal baboon serum 
Average No. of cells  per tube 
15 
1.5 
0.15 
0.015 
InD~0:~ (cells) 
Results 
5/5" 
2/5 
0/5 
0/5 
3.8 
Cells  plus  baboon antiserum 
Average No. of ceils per tube 
30 
3 
0.3 
0.03 
InDs0 (cells) 
Results 
5/5 
3/4 
1/5 
0/5 
1.4 
* Number tubes showing interference/number tubes tested. 
Inhibitory doses0 calculated by method of Reed and Muench. 
Similar experiments were performed with R-3 lung cells at 2 passage levels 
(Table  III). The  number  of cells  capable  of conferring interference  was  es- 
sentially the same at both passage levels. Studies of the same R-3 cell strain at 
its  2nd  passage level from the  patient  also  showed  interference  in  all  tubes 
inoculated  with  5  cells/tube,  the least number  of  cells  tested.  Other  experi- 
ments, such as that shown in Table VI with the R-1 cell strain, indicated that 
a single cell from the carrier culture could be found to confer interference. No 
interference was produced in  GMK monolayers inoculated  with 3000  control 
lung cells  (C-I). These data suggest that virtually all cells of the population 
are producing rubella virus and  that  this  high proportion  of infected cells is 
established early in the life of the cultures. 
The number of cells  capable of conferring interference  to  GMK cells was 
noted to be the same in the presence or absence of rubella antiserum. This im- 
plied a nonneutralizable or intracellular position of the virus, which was further 
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Experiment.--Infected  cells from the R-3 lung cultures were prepared as above and one 
half of the cells were disrupted by sonication. To one half of the sonicated cells was added 
10% normal baboon serum while the other half received 10% rubella antiserum. After 1 hr 
at room temperature the mixtures of sonicated material and whole ceUs were diluted and in- 
oculated onto GMK monolayers. Following an incubation period of 2 wk the GMK mono- 
layers were challenged with echovirus 11. 
It was found that the disrupted cells treated with rubella antiserum did not 
produce interference at concentrations derived from an equivalent of 120 cells 
(Table IV). Thus the virus appears to be in an intracellular position. 
TABLE  III 
The Number of R-3 Lung Cells Infected at Different Passage Levels 
Passage 7  Passage 10 
Cells without serum  Ceils without serum  Cells plus antiserum 
Averageper  tubeN°'  cell  Res~ 
230  7/7* 
23  7/7 
2.3  5/7 
o.23  I  o/7 
Averageper  NO.tube  cells  Res~ 
270  5/5 
27  5/5 
2.7  2/5 
0.27  I  0/5 
Average No. cells  per tube  Resul~ 
180  5/5 
18  s/s 
t.8  1/s 
0.18  1/5 
InDso~: (cells)  1.5  InDoo (cells)  7  InD~o (cells)  6 
* Number tubes showing interference/number tubes tested. 
:~ Inhibitory dose+o calculated by method of Reed and Muench. 
The perpetuation of virus in the carrier state necessitates its spread from cell 
to cell. Viruses which are cytolytic usually are transferred from infected cell to 
new host cell by means of the fluid phase of the culture. However, noncytolyfic 
viruses may be passed to daughter cells during cell division. The ability to rid 
chronically infected cells of persistent virus implies a fluid phase in the cell-to- 
cell transfer of virus and not a  passage  of virus during cell division. Several 
attempts  to cure the  spontaneously rubella infected cell strains  were unsuc- 
cessful. Amantadine-HC1 has been reported to inhibit rubella replication  (33), 
the apparent mechanism of action being prevention of virus penetration (34). 
However, amantadine-HC1 at concentrations adequate to suppress virus pro- 
duction was  toxic to the chronically infected cells.  Similar toxic effects have 
been reported for human diploid cells experimentally infected with rubella (35). 
Rubella  antisera incorporated into  the medium  were also  not  effective in 
curing the chronically infected cell strains. One such attempt is exemplified in 
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Experimeut.--Chronically infected cells were planted in 1-oz. bottles. To one half of the 
bottles was added regular medium while the other half regularly received growth medium plus 
10% human convalescent rubella antiserum having an antibody titer of 1/64.  Medium was 
changed twice weekly and the fluid removed was periodically titered for virus. 3 wk after the 
onset of treatment the number of cells capable of conferring interference with echovirus 11 
in GMK ceils was determined by the terminal dilution method described above. 
TABLE IV 
Rubella Antibody Neutralization of Interfering Agent Obtained  from Ruptured Cells 
of Carrier Culture 
Average No. cells  per tube 
120 
12 
1.2 
0.12 
R-3 cells  plus rubella 
antiserum 
7/7* 
7/7 
2/7 
0/7 
Results 
R-3 sonicated  cells 
Normal serum 
7/7 
4/7 
2/7 
0/7 
Rubella antiserum 
O/7 
017 
0/7 
0/7 
* Number of tubes showing interference/number tubes tested. 
TABLE V 
TheEffed~ Antiswumon T@s~ CaltureFlu~ ~r~ 
Days of treatment 
Cultures 
3  7  14 
With antiserum  < 1. O*  1.2  1.4 
Without antiserum  2.5  3.4  4.2 
* Reciprocal of log InDs0. 
The results of rubella virus titers are summarized in Table V and it can be 
seen  that  complete suppression  of  virus  in  the  tissue  culture  fluid  was  not 
achieved.  No evidence of virus was found  at a  10-foM  dilution  of the  tissue 
culture fluid after 3 days of treatment with  antiserum; however, at  7 and  14 
days  interference  was  produced  in  GMK  ceils  inoculated  with  fluid  at  this 
dilution.  The decrease of 2 and 3 log InD60 of virus in the tissue culture fluid 
at 7 and  14 days does not appear to be due to a  change in the proportion of 
cells capable of producing virus (Table VI). Similar results were obtained using 
the hyperimmune antiserum prepared in baboons. In this experiment rubella 
virus was not detected in the undiluted culture fluid for 6 days, but thereafter 
the virus titer gradually increased. 
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death would be anticipated in a viral carrier state in which the virus was trans- 
ferred to daughter  cells during cell division. An effort was made to isolate in- 
dividual cells and maintain them for a  period of time which would allow any 
viral cytopathic effects and inactivation of the virus produced to occur.  This 
was accomplished in capillary tubes. 
TABLE VI 
Effect of 3-~ok Treatment of Cultures with Antiserum on the Number of Cells Capable 
of Producing Interference 
Cells from control cultures  Cells from treated cultures 
Average No. cells per tube  Results  Average No. cells per tube  Results 
120  7/7*  130  7/7 
12  7/7  13  7/7 
1.2  1/7  1.3  3/7 
0.12  1/7  O. 13  3/7 
InDso (cells)  1  InDso (ceils)  0.8 
* Number tubes showing interference/number tubes tested. 
TABLE VII 
Interference Produced by Single R-3 Cells after Incubation for 1 Month in Capillary Tubes 
Control rubella  virus from  fluid  Infected R-3 cells  Control cells  phase of R-3 cultures 
13~2" 
* Number tubes producing interference/number tubes tested. 
l~xperiment.--R-3  lung cells in passage 7 were prepared in cell suspensions  as described 
above for determining the proportion of cells infected. They were diluted in growth medium 
to a concentration of 20 cells per ml. Approximately 0.1 ml portions of the cell suspensions 
were drawn into 1.6 to 1.8 X  100 mm capillary tubes which were then flame sealed. The tubes 
were incubated at 37°C for 1 month after which they were broken and the contents of each 
capillary tube emptied into a culture tube containing GMK cells. The medium was changed 
in 7 days and after 2 wk the GMK monolayers were inoculated with 100 TCD60 echovirus 11. 
Capillary tubes containing control C-2 cells and tubes containing cell-free R-3 tissue culture 
fluid were handled similarly. 
Small opaque  areas were noted in some capillary tubes; however,  a  proper 
optical system to delineate individual cells within the tubes was not available. 
The  results  of the production  of interference in  GMK  cells by  the capillary 
tube contents are shown in Table VII. Cells from the early subcultures of R-3 
apparently survived for 1 month in the capillary tubes, for 40 %  of these tubes 806  RIYBELLA  VIRUS  CARRIER  CULTURES 
contained sufficient virus to produce interference against echovirus 11 in GMK 
cells.  These results also imply a  high proportion  of the ceils introduced into 
the capillary tube were infected with the virus. Of importance is the fact that 
chronically infected cells could be isolated in capillary tubes where  they  ap- 
parently survived and produced virus.  Control noninfected cells and cell-free 
virus containing fluid did not confer interference in GMK cells after an incuba- 
tion  period  of  1  month  under  similar  circumstances.  The  interfering  agent 
produced in the capillary tubes by the chronically infected cells could be passed 
and was neutralized with rubella antiserum. 
Definite  evidence of passage of virus  to daughter  cells during  cell division 
can be obtained in developing clones of infected cells under circumstances pre- 
venting transfer of virus through tissue culture fluid. Although 22 cell doublings 
"or  splits"  are theoretically necessary to produce  10  e cells from a  single cell 
(36),  and  the number  of splits  of chronicaUy infected cell strains  before  the 
pattern  of  slow  growth  occurred  were  far fewer,  attempts  to  clone  infected 
ceils were made. One such attempt is described below. 
Experiment.--R-5 kidney ceils, passage 3, were trypsinized, washed with growth medium, 
and individual cells (or double or triple cell aggregates) were placed in constricted tubes using 
a microcapillary technique. $~ ml of growth medium was added to the tubes and the pH of 
the medium adjusted with CO2.  The tubes were incubated in a stationary rack and they were 
periodically examined for cells. After 3 wk of incubation the medium was transferred to GMK 
monolayers which were incubated for 2 wk and then challenged with 100 TCDs0 echovirus 11. 
Examination of the tubes revealed 13 of 41 tubes in which the cells apparently 
did not survive. Fluid from these tubes failed to produce interference in GMK 
ceils.  There were  15  tubes  in which  individual  cells developed into  clones  of 
cells ranging from 4 to 16 in number. The number of cells in each clone reached 
a  maximum after which  the cells gradually underwent  degenerative changes. 
Fluid from 7 of the 15 tubes produced interference in GMK cells. Two or more 
cells  were inoculated  into  13  tubes  and  the fluid from 12  of these  produced 
interference in GMK cells. 
Cells of viral carrier states have often been found to have altered suscepti- 
bility to superinfection with a second virus; this has been especially true where 
interferon has been responsible for maintaining the carrier state. Studies of the 
viral susceptibility of the rubella virus carrier cultures were undertaken.  Since 
noninfected clones of the spontaneously infected cell strains could not be estab- 
lished, the virus susceptibility of the chronically infected cell strains was com- 
pared with the normal cell strains derived from similar tissues of other infants. 
Experiment.--Cells were planted at 5  to  10  X  104/mi in constricted culture tubes.  When 
confluent monolayers had developed the medium was removed and the tubes were inoculated 
with 0.1 nil of the appropriately diluted virus. 10-fold dilutions of each test virus were made 
in Earle's solution and 4 tubes were inoculated per dilution. After 1 hr at room temperature, 
1 ml of maintenance medium was added to the tubes which were observed 3 times weekly for WILLIAM  E.  RAWLS  AND  JOSEPH  L.  MELIN-ICK  807 
2 wk. Cytopathic effect involving more than 25% of cells of the monolayer was considered 
as positive evidence of viral effect. 
Chronically infected cells were found to be resistant to the cytopathic effects 
of VSV and herpes simplex virus, the differences in virus titers between nonin- 
fected and chronically infected cell strains being 3 log10 or greater (Table VIII). 
Echovirus 11 developed slightly more slowly in chronically infected cells than 
in noninfected  cells but  eventually similar  titers  were obtained  in both  cells, 
based on the appearance of enteroviral cytopathic changes. 
The  failure  of VSV  and  herpes  simplex  but  not  echovirus  11  to produce 
cytopathic changes in the carrier cultures raised the question of replication of 
these  different  viruses  in  the  cells.  Therefore  the  growth  characteristics  of 
TABLE VIII 
Virus Susceptibility of Rubella-Infected and Control-Noninfected Cdl Strains 
Rubella-infected cell strains  Control  noninfected cell strains 
Virus  _ _  I 
Echovirus  11 
Herpes 
simplex 
Vesicular 
stomatitis 
R-1 
Thyroid 
6* 
<1 
<1 
R-2 
UmbiHcus 
5.3;6.2 
<1; <2 
<1;  <I 
R-3 Lung 
6.0; 6.3 
2.5; 2.5 
<1; 1.5 
R-4 
Bone 
marrow 
5.3 
<1 
<1 
C-1 Lung 
5.7:6.5 
5.7; 6.7 
4.5:5.5 
C-2 Lung 
5.5; 5.7 
5.5; 5.5 
5.3; 5.5 
C-3  [  C-4 
I.mbil-  Thyroid 
ICUS 
7.0  [  7.0 
7.3  6.3 
6.3  5.7 
* Reciprocal of highest dilution  (Logt0) producing CPE/0.1 ml. 
echovirus 11  and VSV were examined in chronically infected and noninfected 
cell strains. 
Experiment.--Ceil  monolayers in constricted culture tubes were washed with Earle's solu- 
tion and inoculated with an input multiplicity of about 2 to 4 PFU virus/cell.  Virus was al- 
lowed to adsorb  1 hr at 37°C. The monolayers were washed once with Earle's solution and 
aliquots of wash material were titered for unadsorbed virus. Maintenance medium was added 
to the culture tubes which were then incubated at 37°C. Three tubes for each cell strain were 
removed at appropriate  intervals  and frozen. The total virus was determined by 3 cycles of 
freezing and thawing of the tubes, pooling their contents, and assaying the pooled material. 
Replication of both viruses was examined in 3 chronically infected cell strains, 
and in 3 control noninfected cell strains. Fig. 4 contains a representative growth 
curve of echovirus 11 in spontaneously infected R-3 lung cells, control C-2 lung 
cells,  and  experimentally  infected  GMK  cells.  The  only difference  noted  be- 
tween chronically infected and  control  noninfected  human  cells  was  0.5  to  1 
log less virus yield in the chronically infected cells. No evidence of echovirus 11 
replication was found in GMK cells which had been infected with rubella virus 808  RIYBELLA  VIRUS  CARRIER  CITLTI.YRES 
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FIo. 4. The replication  of echovirus  11 in R-3 lung rubella carrier  cultures  (1.4 X  l0  s 
ceUs/culture), C-1 lung control cultures (4 X  l0  s cells/culture),  and GMK cultures  (4 X  106 
cells/culture)  infected with rubella virus from R-3 lung cultures. 
from R-3  tissue  culture fluid 5  days before  the  introduction  of echovirus  11. 
Unlike  echovirus  11,  vesicular  stomatitis  virus  did  not replicate  significantly 
in the chronically infected cell strains (Fig. 5). 
Virus titers in wash material from growth curve experiments were essentially 
the  same  for  rubella-infected  and  control-noninfected  cells  implying  similar 
adsorption dynamics. The nature of adsorption was examined more closely for WILLIAM  E.  PAWLS  AND  JOSEPH  L.  MELNICK 
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FIG. 5.  The replication of vesicular stomatitis virus in R-2 umbilicus carrier cultures (6 X 
104 cells/culture), and C-3 umbilicus control cultures (25 X  104 cells/culture). 
vesicular stomatitis virus in two chronically infected cell strains, (R-3 lung and 
R-2 umbilicus) and a  control noninfected cell strain (C-1 lung). 
Experiment.--Monolayers of cells were dispersed  by trypsinization, washed,  and resus- 
pended in maintenance medium at pH 8. To 2.5 ml of cells (5 X  105/ml) were added 5 X  106 
PFU of vesicular stomatitis virus in 0.1 ml. The suspensions were incubated at room tempera° 
ture with periodic manual agitation. Portions (0.2 ml) of cell suspensions were removed at 
15-rain intervals and diluted 25 times in maintenance medium. The cells were immediately 810  RUBELLA  VIRUS  CARRIER  CULTURES 
TABLE  IX 
Adsorption of VSV* on Rubdla-Infected and Control-Noninfected Cells 
15 rain  30 mln  45 min  60 rain 
2en strains 
~-3 lung 
R-2 um- 
bilicus 
2-1 lung 
PFU/0.1 ml 
supernate 
2.4X  10  3 
2.3 X  10  8 
2.0 X  10  3 
Ad- 
sorbed 
% 
25 
28 
37 
PFU/0.1 ml 
supemate 
1.7 X  10  3 
i.6X  10  8 
1.4 X  10  3 
Ad- 
sorbed 
% 
47 
50 
56 
PFU/0.1 ml 
supernate 
1.1  X  103 
1.2 X  103 
Ad- 
sorbed 
% 
66 
62 
PFU/0.1 ml 
supernate 
tXI(P 
9X  10  2 
t.t X  t0  ~ 
sorAbtd 
% 
69 
72 
66 
* Input virus titer, 3.2 X  103 PFU/0.1 ml. 
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FIG.  6.  Eclipsing of vesicular stomatifis virus in R-1 thyroid carrier culture cells and C-4 
thyroid control cells. 
sedimented by centrifugation at  1500 Rl,  u  for 10 min and residual virus in the supernatant 
fluid was assayed. Virus content of medium treated similarly but without the presence of cells 
was also determined. 
No difference in adsorption was noted (Table IX).  Consequently the lack of 
growth  of VSV in chronically infected cells must  be due to some other factor. WILLIAM E.  PAWLS  AND  JOSEPH  L.  MELNICK  811 
Further efforts to characterize the lack of replication of VSV were made by 
investigating the eclipse of the virus in infected and noninfected cells. 
Experimo~.--Tnfected and control cell monolayers  were  trypsinized  and  the  cells sedi- 
mented by low speed centrifugation. The cells (106) were resuspended in 1 ml of cold growth 
medium containing  107 TCDs0 VSV. The suspensions were agitated for a  few minutes,  then 
the cells were sedimented at 3000 ~rr for 30 sec. The cells were washed 3  times in 10 ml of 
cold Eagle's medium without serum,  resuspended  in 10 ml of the same medium,  and placed 
at 37°C. 1 ml portions were removed  at appropriate intervals and immediately frozen in a 
dry ice-alcohol bath.  When all samples had been collected,  they were thawed and frozen 2 
additional times and assayed for virus. 
The results of an experiment utilizing R-1 thyroid and C-4 thyroid are shown 
in Fig. 6. There was no indication of a significantly impaired eclipsing of VSV 
in the 3  rubella-infected cell  strains  examined. These data indicate an intra- 
cellular site of interference with VSV  replication in the chronically infected 
cell strains. 
DISCUSSION 
Rubella virus carrier cultures have been induced in stable cell lines (37-39). 
Cell strains derived from certain tissues (skin and pharyngeal mucosa) of human 
embryos were also found to survive in a carrier state when experimentally in- 
fected with rubella virus (40). In addition, Kay et al. (41) and Goffe (42) have 
reported the isolation of rubella virus from tissue cultures derived from fetuses. 
Sufficient information is not available, however, to compare the artificially in- 
duced carrier cultures with those developing spontaneously from tissues of con- 
genitally infected patients.  The spontaneous carrier cultures reported in  our 
paper are characterized by the following: (a)  no rubella antiserum or serum 
inhibitors are necessary to maintain the cultures; (b)  virtually the entire cell 
population is infected with rubella virus; (6) the virus does not appear to have 
a  cytolytic potential in the cells which are able to survive and produce virus 
for long periods; (d) the infected cells are resistant to superinfection by some 
viruses but not by others; and (e) no evidence could be obtained to show that 
interferon plays a role in maintaining the carrier state. 
Experimentally induced carrier cultures with similar virus-cell relationships 
have been described for mumps (43) and parainfluenza (44) in stable cell lines. 
In both of these systems direct evidence of the passage of virus from parent to 
daughter  cells  was  demonstrated.  Although  direct  evidence for  this  type of 
transfer of virus in cells chronically infected with rubella was not  obtained, 
the development of clones of cells which were infected makes this type of cell 
transfer likely. 
The absence of interference to superinfection of rubella-infected cell strains 
with echovirus 11  confirms the finding of Goffe (42). Variability in resistance 
to superinfection of carrier cultures with related and unrelated viruses has been 
noted by others (43, 45, 46).  Crowell (46) found specific resistance to related 812  RUBELLA  VIRUS  CARREER  CULTUI~S 
enteroviruses and this resistance was found to be an adsorption defect, which 
was not demonstrated to be the case in our rubella-infected cells.  The mecha- 
nism  of maintenance  of  the  enterovirus  carrier  state  reported  by  Crowell, 
however, was  quite different from that  operative in  the rubella-infected cell 
strains. In the case of HeLa cells persistently infected with tick-borne enceph- 
alitis virus, Mayer (45) found them to be relatively resistant to infection with 
poliovirus 1 andcoxsackievirus B1 but sensitive to infection with herpes simplex 
virus (45). The mumps carrier cultures described by Walker (43) were resistant 
only to superinfection with another strain of the same virus. The nature of the 
interference noted in  the latter  two instances  is not clear. Whether they re- 
semble the intracellutar block of viral synthesis as noted for VSV in the rubella 
carrier cultures remains to be determined. 
Interference produced by rubella virus in human amnion and bovine embryo 
ceils has been attributed to interferon (47); however, no interferon was detected 
in  GMK cultures infected with rubella virus  (48).  Interference of Newcastle 
disease virus by rubella virus in GMK cells has been described which does not 
appear to be mediated by an interferon (49). In this instance, as with VSV in 
chronically infected cells, there appears to be normal attachment and eclipse 
of the challenge virus. Evidence has been presented to suggest that the virus 
infection of a cell may result in either the production of virus or the production 
of interferon (50, 51). If a similar chain of events occurred with rubella-infected 
cells it would be difficult to postulate an interferon-mediated action as a mecha- 
nism for the viral carrier state in which virtually the entire population of cells 
were already infected with the virus (28). 
Postulation of in vivo events from in vitro observations is hazardous; how- 
ever, some  comment on the possible nature  of the in  vivo rubella virus-cell 
relationship in congenital rubella is  in  order. In  the cells derived from these 
infants the virus has been shown to survive and replicate without producing 
cell death. Virus appears to be transferred from parent to daughter cells during 
cell division,  thus it can be envisioned that parent cells infected early in em- 
bryonic life may give rise to clones of infected cells.  Cell transfer of virus under 
these circumstances would not be affected  by circulating antibodies. Hayflick has 
suggested a  possible relationship between the in vitro life span of cell strains 
and in vivo ageing (36). The slower growth and possible shortened survival of 
the chronically infected cells observed in vitro would suggest limited doubling 
potential of the in vivo infected cell clones, which upon dying out should result 
in spontaneous cure of the infants.  Cessation of excretion of virus by infants 
with rubella apparently does occur (13,  52).  Naeye and Blanc have recently 
demonstrated that organs of infants with congenital rubella contain subnormal 
numbers of cells (53). These findings are in keeping with the hypothesis that 
clones of infected cells have a limited doubling potential. Whether or not virns- 
infected cells in the congenital rubella infants themselves respond to produce WILLIAM E. KAWLS  AND  JOSEPH L. MELNICK  813 
interferon is unknown, but our studies failed to reveal interferon production by 
the chronically infected cells in culture. Interferon production is a manifesta- 
tion of the cellular response to foreign substances such as nucleic acids (54). 
Rubella virus infection of cells  during the early developmental stages of the 
embryo could result in the incorporation of the virus into the cell at a  time 
when it would not be recognized as foreign; and thus interferon production would 
not be stimulated. Experimental evidence for such a period of decreased pro- 
duction of interferon during early development has been demonstrated in chick 
embryos (55).  In the human embryo, the number of cells which might not be 
capable of recognizing the rubella virus as foreign would have to be limited. 
Involvement of all the body cells including the antibody forming cells should 
result in complete immunologic tolerance similar to that observed in mice in- 
fected in utero with lymphocytic choriomeningitis virus (56). However, unlike 
mice which are reported not to receive significant amounts of maternal anti- 
bodies transplacentally (57),  the extent of involvement in the human embryos 
might be confined to a limited number of clones by maternal antibodies (11). 
SUMMARY 
Spontaneous rubella carrier cultures derived from tissues of infants with con- 
genital rubella were studied in an attempt to elucidate a  possible mechanism 
for viral persistence observed in these infants. Chronically infected cells were 
found to have  a  reduced  growth rate  and  the  cultures  appeared  to have  a 
shortened life span.  The  rubella  carrier  state  was not dependent  on  serum 
inhibitors or rubella antibodies. Virtually every cell in the carrier population 
was found to be producing virus. The carrier cultures could not be cured by 
rubella antibodies.  The rubella-infected cells  were resistant to superinfection 
with vesicular stomatitis virus and herpes simplex virus but were susceptible 
to infection with echovirus 11. The replication of vesicular stomatitis virus was 
apparently blocked at an intracellular site, for the virus readily adsorbed to the 
chronically infected cells and entered into an eclipse phase; however no infec- 
tious virus  developed.  No  evidence of  interferon production by  these  cells 
could be obtained. It is postulated that clones of rubella-infected cells in vivo, 
with properties similar to those in carrier cultures developed in vitro from tissues 
of in utero infected infants, might explain the observed viral persistence noted 
in congenital rubella. 
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